A significant time-dependent increase in caspase 3/7 positive U-87 and LN229 cells was observed after combination therapy, which was higher when compared to AF/pPBS monotherapy treatments (Figure 3a,b). This evidence concerns the gene CASP3 and atrial fibrillation.